Menu
No results found.
Weekly Share Price & Valuation Overview
Sotera Health Company
Sotera Health Company provides sterilization, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment offers outsourced terminal sterilization and irradiation services using gamma irradiation, ethylene oxide processing, and electron beam irradiation technologies for the medical device, pharmaceutical, and food safety and advanced applications markets. The Nordion segment provides Cobalt-60 used in the sterilization and irradiation processes for the medical device, pharmaceutical, food safety, and high-performance materials industries, as well as in the treatment of cancer. It also offers gamma irradiation systems. The Nelson Labs segment provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2015 and is headquartered in Broadview Heights, Ohio.
- Healthy operating margin (≥15%) indicates efficient core operations.
- High gross margin (≥35%) suggests strong pricing power or cost control.
- ROA ≥7% shows efficient use of assets.
- Quick ratio ≥1.0 indicates obligations can be met without inventory.
- Debt-to-equity >2 — elevated leverage may constrain flexibility.
- Debt/EBITDA >4 — elevated leverage vs earnings capacity.
- Market Cap Total equity value of the company (share price × shares outstanding).
- USD 4.47B
- Enterprise Value Operating value: market cap + total debt − cash.
- USD 6.49B
- Total Revenue (TTM) Sales over the last twelve months. May be estimated from revenue per share when inconsistent.
- USD 1.12B
- Gross Profit (TTM) Revenue minus cost of goods sold over the last twelve months. Hidden for financial institutions or if redundant.
- USD 624.44M
- EBITDA (TTM) Earnings before interest, taxes, depreciation and amortization (TTM). Hidden for financials or if implausible.
- USD 525.32M
- Revenue per Share (TTM) Total revenue divided by shares outstanding (may be estimated).
- USD 3.97
- EPS (TTM) Earnings per share over the last twelve months (may be estimated from net income ÷ shares).
- 0.09
- Shares Outstanding
- 284.05M
- Float Shares
- 133.84M
- Implied Shares Outstanding
- 284.05M
- Operating Margin (TTM) Strong Operating income ÷ revenue over the last twelve months (reconciled when possible).
-
35.34%
- EBITDA Margin (TTM) Reconciled EBITDA ÷ revenue over the last twelve months (suppressed if EBITDA implausible/financials).
-
46.71%
- Gross Margin (TTM) Reconciled Strong Gross profit ÷ revenue over the last twelve months (reconciled when possible).
-
55.53%
- Profit Margin (TTM) Net income ÷ revenue over the last twelve months (reconciled when possible).
-
2.14%
- ROA Strong Return on assets: net income ÷ total assets.
-
7.24%
- ROE Return on equity: net income ÷ shareholder equity.
-
5.14%
- Revenue Growth Year-over-year revenue growth.
-
6.40%
- Earnings Growth (YoY) Year-over-year earnings growth.
-
-6.50%
- Earnings Growth (QoQ) Quarter-over-quarter earnings growth.
-
-9.00%
- Quick Ratio Adequate Liquid current assets ÷ current liabilities (ex-inventory).
- 2.08
- Debt to Equity Total debt ÷ shareholder equity; leverage.
- 4.60
- Total Cash Cash and equivalents.
- USD 332.63M
- Total Debt Short + long-term interest-bearing debt.
- USD 2.35B
- Net Debt Total debt − cash (negative = net cash).
- USD 2.02B
- Debt / EBITDA Leverage relative to operating earnings; lower is safer.
- 4.48
- Operating Cash Flow (TTM) Cash generated by core operations (pre-capex).
- USD 266.11M
- Free Cash Flow (TTM) Cash after capex; funds buybacks, dividends, and debt paydown.
- USD 218.81M
- OCF Margin (TTM) Operating cash flow ÷ revenue (TTM).
-
23.66%
- FCF Margin (TTM) Free cash flow ÷ revenue (TTM).
-
19.46%
- Cash Conversion (OpCF/EBITDA)
- 0.51
- Margins shown on a TTM basis. “Reconciled” = numerator ÷ TTM revenue for internal consistency.
- Cash Flow section is displayed only when figures are self-consistent (and hidden for financials).
Disclaimer: Information is compiled from publicly available sources and is subject to errors and omissions. It is provided as a guide only and does not constitute investment advice. Please do your own research.